Sign in

CIK 0001815776

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

LENZ Therapeutics, Inc.

Sign in to watch
Ticker
LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
844867570
Phone
+1 858-925-7000
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
Former names
Graphite Bio, Inc.
  1. 4 Open-market buy 10% owner bought 201,685 shares at $10.15 ($2,047,103)
  2. 4 Open-market buy 10% owner bought 50,800 shares at an average $13.14 ($667,665)
  3. 4 Open-market buy 10% owner bought 145,496 shares at an average $13.53 ($1,968,973)
  4. 4 Open-market buy 10% owner bought 180,000 shares at $17.00 ($3,060,000)
  5. 4 Conversion CHIEF OPERATING OFFICER acquired 8,126 shares (conversion)
  6. 4 Open-market buy Director bought 180,000 shares at $17.00 ($3,060,000)
  7. 4 Open-market buy Director bought 5,882 shares at $17.00 ($99,994)
  8. 4 Exercise or conversion CHIEF BUSINESS OFFICER acquired 94,789 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 49,876 shares (option exercise)
  10. 4 Conversion Director acquired 8,126 shares (conversion)
  11. 4 Exercise or conversion PRESIDENT AND CEO acquired 374,013 shares (option exercise)
  12. 4 Open-market buy 10% owner bought 500,000 shares at $17.00 ($8,500,000)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 7 · 129 filings